You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent/Metastatic (R/M)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Completed
Has Results
  • Human Papillomavirus (HPV)-Related Malignancies
  • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
  • Basking Ridge, New Jersey
  • +5 more
Dec 14, 2022

Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

Not yet recruiting
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Ficlatuzumab
  • +2 more
  • (no location specified)
Sep 26, 2023

Squamous Cell Carcinoma Trial (MK-3475A)

Not yet recruiting
  • Squamous Cell Carcinoma
  • MK-3475A
  • (no location specified)
Sep 11, 2023

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

Adenoid Cystic Carcinoma of the Head and Neck Trial (OBT076, Balstilimab)

Not yet recruiting
  • Adenoid Cystic Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • inulin
  • +2 more
  • Candiolo, Turin, Italy
    Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Apr 7, 2023

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023

Head and Neck Tumors, Recurrent Disease, Metastatic Cancer Trial in Shanghai (Penpulimab combined with cetuximab)

Active, not recruiting
  • Head and Neck Neoplasms
  • +2 more
  • Penpulimab combined with cetuximab
  • Shanghai, China
    Department of Radiotherapy, Eye & ENT Hospital of Fudan Universi
Mar 1, 2022

NPC Trial in Guangzhou (Sintilimab, IBI310)

Active, not recruiting
  • NPC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 3, 2022

Advanced Malignant Tumor, Delirium, Locally Advanced Malignant Tumor Trial in Houston (Chlorpromazine, Haloperidol,

Active, not recruiting
Has Results
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

First Line Recurrent/Metastatic Squamous Cell Carcinoma of Head

Completed
  • Squamous Cell Carcinoma of the Head and Neck
    • Parsippany, New Jersey
      Medical Data Analytics
    Nov 15, 2021

    Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in Shanghai (Fluzoparib and Camrelizumab)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Nasopharyngeal Cancer
    • Fluzoparib and Camrelizumab
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Jun 4, 2022

    Pembrolizumab in the First Line Therapy for R/M HNSCC in China

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Beijing, China
      Cancer Institute/Hospital, Chinese Academy of Medical Sciences &
    Feb 4, 2022

    Advanced Malignant Tumor, Cancer Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 3, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab combined with Chemotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Pembrolizumab combined with Chemotherapy
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
    Feb 4, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

    Active, not recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +20 more
    • Pembrolizumab
    • Ziv-Aflibercept
    • Tampa, Florida
    • +8 more
    Jan 3, 2023

    Head and Neck Tumors Trial in Tainan, Taipei (SCB01A)

    Terminated
    • Head and Neck Neoplasms
    • Tainan, Taiwan
    • +3 more
    Jun 22, 2022

    Head and Neck Tumors, Carcinoma, Squamous Cell of Head and Neck, Metastasis Trial in Hospitalet de Llobregat, Barcelona (VCN-01,

    Active, not recruiting
    • Head and Neck Neoplasms
    • +3 more
    • VCN-01
    • Durvalumab
    • Hospitalet de Llobregat, Barcelona, Spain
    • +1 more
    Mar 25, 2022

    Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai

    Recruiting
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • Shanghai, China
      the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
    Dec 5, 2021

    HNSCC Trial in United States (Tipifarnib, Alpelisib)

    Recruiting
    • HNSCC
    • Duarte, California
    • +10 more
    Jun 30, 2022

    Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab, Sintilimab, Chemotherapy drug)

    Not yet recruiting
    • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    May 6, 2021

    Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)

    Not yet recruiting
    • Gland
    • Salivary Gland Cancers
    • Sacituzumab Govitecan
    • Houston, Texas
      M D Anderson Cancer Center
    May 22, 2023

    Gynecological Malignancies Trial in Beijing (BL-M07D1)

    Not yet recruiting
    • Gynecological Malignancies
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Nov 15, 2023

    Cervical Cancer Trial in Wuhan (Cadonilimab, Anlotinib)

    Recruiting
    • Cervical Cancer
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Apr 5, 2023

    HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma Trial in France, Spain, United

    Recruiting
    • HPV-Related Carcinoma
    • +4 more
    • Jacksonville, Florida
    • +16 more
    Feb 14, 2022